Celldex Therapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by TD Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $9.5M | 226k | 41.97 |
| 2023-12-31 | $2.1M | 52k | 39.66 |
| 2023-09-30 | $1.8M | 65k | 27.52 |
| 2023-06-30 | $1.1M | 33k | 33.93 |
| 2023-03-31 | $1.6M | 46k | 35.98 |
| 2022-12-31 | $2.5M | 55k | 44.57 |
| 2022-09-30 | $1.4M | 48k | 28.35 |
| 2022-06-30 | $988k | 37k | 26.95 |
| 2022-03-31 | $2.5M | 74k | 34.07 |
| 2021-12-31 | $2.4M | 62k | 38.63 |
| 2021-09-30 | $3.4M | 62k | 53.99 |
| 2021-06-30 | $2.0M | 45k | 43.76 |
| 2021-03-31 | $471k | 23k | 20.61 |
| 2020-12-31 | $287k | 16k | 17.50 |